These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20656224)

  • 1. Paclitaxel-induced arterial wall toxicity and inflammation: tissue uptake in various dose densities in a minipig model.
    Radeleff B; Lopez-Benitez R; Stampfl U; Stampfl S; Sommer C; Thierjung H; Berger I; Kauffmann G; Richter GM
    J Vasc Interv Radiol; 2010 Aug; 21(8):1262-70. PubMed ID: 20656224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-induced arterial wall toxicity and inflammation: part 2--long-term tissue response in a minipig model.
    Stampfl U; Radeleff B; Sommer C; Stampfl S; Lopez-Benitez R; Thierjung H; Kurz P; Berger I; Richter GM
    J Vasc Interv Radiol; 2009 Dec; 20(12):1608-16. PubMed ID: 19944986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform.
    Thompson CA; Huibregtse B; Poff B; Wilson GJ
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):597-604. PubMed ID: 19180652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model.
    Radeleff B; Thierjung H; Stampfl U; Stampfl S; Lopez-Benitez R; Sommer C; Berger I; Richter GM
    Cardiovasc Intervent Radiol; 2008; 31(5):971-80. PubMed ID: 18095019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
    Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
    Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents.
    van Beusekom HM; Sorop O; van den Heuvel M; Onuma Y; Duncker DJ; Danser AH; van der Giessen WJ
    EuroIntervention; 2010 May; 6(1):117-25. PubMed ID: 20542807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local paclitaxel delivery after coronary stenting in an experimental animal model.
    Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
    Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.
    Scheller B; Speck U; Abramjuk C; Bernhardt U; Böhm M; Nickenig G
    Circulation; 2004 Aug; 110(7):810-4. PubMed ID: 15302790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.
    Radke PW; Joner M; Joost A; Byrne RA; Hartwig S; Bayer G; Steigerwald K; Wittchow E
    EuroIntervention; 2011 Oct; 7(6):730-7. PubMed ID: 21986331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel?
    Speck U; Cremers B; Kelsch B; Biedermann M; Clever YP; Schaffner S; Mahnkopf D; Hanisch U; Böhm M; Scheller B
    Circ Cardiovasc Interv; 2012 Jun; 5(3):392-400. PubMed ID: 22619258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting balloons for percutaneous coronary interventions.
    Zimarino M; De Caterina R
    Thromb Haemost; 2009 Jan; 101(1):9-11. PubMed ID: 19132182
    [No Abstract]   [Full Text] [Related]  

  • 15. Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model.
    Wilson GJ; Polovick JE; Huibregtse BA; Poff BC
    Cardiovasc Res; 2007 Nov; 76(2):361-72. PubMed ID: 17716637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries.
    Shinke T; Geva S; Pendyala L; Jabara R; Li J; Chen JP; Venegoni A; Colley K; Klein R; Chronos N; Robinson K; Hou D
    Int J Cardiol; 2009 Jun; 135(1):93-101. PubMed ID: 18692915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating.
    Jabara R; Chronos N; Conway D; Molema W; Robinson K
    JACC Cardiovasc Interv; 2008 Feb; 1(1):81-7. PubMed ID: 19393150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local drug delivery - the early Berlin experience: single drug administration versus sustained release.
    Speck U; Scheller B; Rutsch W; Laule M; Stangl V
    EuroIntervention; 2011 May; 7 Suppl K():K17-22. PubMed ID: 22027723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries.
    Pósa A; Nyolczas N; Hemetsberger R; Pavo N; Petnehazy O; Petrasi Z; Sangiorgi G; Gyöngyösi M
    Catheter Cardiovasc Interv; 2010 Sep; 76(3):395-403. PubMed ID: 20839356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.